• 1
    Gajwani P, Forsthoff A, Muzina D et al. Antiepileptic drugs in mood-disordered patients. Epilepsia 2005; 4: 3844.
  • 2
    Yatham LN, Kusumakar V, Calabrese JR et al. Third generation anticonvulsants in bipolar disorder: A review of efficacy and summary of clinical recommendations. J. Clin. Psychiatry 2002; 63: 275283.
  • 3
    Johnson BA, Ait-Daoud N, Bowden CL et al. Oral topiramate for treatment of alcohol dependence: A randomized controlled trial. Lancet 2003; 361: 16771684.
  • 4
    Johnson BA, Ait-Daoud N, Akhtar FZ, Javors MA. Use of oral topiramate to promote smoking abstinence among alcohol-dependence smokers. Arch. Intern. Med. 2005; 165: 16001605.
  • 5
    Khazaal Y, Cornuz J, Bilancioni R, Zullino DF. Topiramate for smoking cessation. Psychiatry Clin. Neurosci. 2006; 60: 384388.
  • 6
    Bray GA, Hollander P, Klein S, Kushner R, Brian Levy B. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes. Res. 2003; 11: 722733.
  • 7
    Appolinario JC, Fontenelle LF, Papelbaum M, Bueno JR, Coutinho W. Topiramate use in obese patients with binge eating disorder: An open study. Can. J. Psychiatry 2002; 47: 271273.
  • 8
    Shapira NA, Goldsmith TD, McElroy SL. Treatment of binge-eating disorder with topiramate: A clinical case series. J. Clin. Psychiatry 2000; 61: 368372.
  • 9
    McElroy SL, Arnold LM, Shapira NA et al. Topiramate in the treatment of binge eating disorder associated with obesity: A randomized, placebo-controlled trial. Am. J. Psychiatry 2003; 160: 255261.
  • 10
    De Bernadi C, Ferraris S, D'Innella P, Do F, Torre E. Topiramate for binge eating disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005; 29: 339341.
  • 11
    Nickel C, Tritt K, Muehlbacher M et al. Topiramate treatment in bulimia nervosa patients: A randomized, double-blind, placebo-controlled trial. Int. J. Eat. Disord. 2005; 38: 295300.
  • 12
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revised, 4th edn (DSM-IV-TR). American Psychiatric Association, Washington, DC, 2000.
  • 13
    Levy J, Yagev R, Petrova A, Lifshitz T. Topiramate-induced bilateral angle-closure glaucoma. Can. J. Ophthalmol. 2006; 42: 211215.
  • 14
    Werneke U, Taylor D, Sanders TA. Options for pharmacological management of obesity in patients treated with atypical antipsychotics. Int. Clin. Psychopharmacol. 2002; 17: 145160.